Concepedia

Ahmed M. Metwaly

AM

Statistics

Publications

111

Citations

4.4K

H-Index

40

Active since

2013

Affiliations

Al-Azhar University(Current)

Almaarefa University

Alfaisal University

City of Scientific Research and Technological Applications

Princess Nourah bint Abdulrahman University

Ahmed M. Metwaly is an author at Al-Azhar University specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

2013–2025

111

Publications

111

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor

Ahmed A. Al‐Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly et al. · Frontiers in Chemistry · 2021 · 275 citations · Full text

, , +17

Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers

Hazem A. Mahdy, M.K. Ibrahim, Ahmed M. Metwaly et al. · Bioorganic Chemistry · 2019 · 168 citations

, , +17

Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors

M.K. Ibrahim, Mohammed S. Taghour, Ahmed M. Metwaly et al. · European Journal of Medicinal Chemistry · 2018 · 129 citations · Full text

, , +15

Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects

Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady et al. · Molecules · 2022 · 120 citations · Full text

, , +17

Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation

Khaled El‐Adl, Helmy Sakr, Reda G. Yousef et al. · Bioorganic Chemistry · 2021 · 108 citations

, , +13

1–5 of 111